Secondary Hyperparathyroidism
10.21614/chirurgia.114.5.541

The Value of Imaging of the Parathyroid Glands in Secondary Hyperparathyroidism.


Secondary Hyperparathyroidism
10.14744/TurkPediatriArs.2019.93206

Is hepcidin related with anemia and bone mineral metabolism in children with non-dialysis chronic kidney disease?


Secondary Hyperparathyroidism
10.1210/JS.2019-SAT-500

SAT-500 Osteoblastic Metastasis in Prostate Cancer: A Sink Trap for Calcium in a Patient with Concomitant Secondary Hyperparathyroidism and Metastatic Prostate Cancer


Secondary Hyperparathyroidism
10.1371/journal.pone.0216399

Effectiveness of cinacalcet treatment for secondary hyperparathyroidism on hospitalization: Results from the MBD-5D study


Secondary Hyperparathyroidism
10.1080/02656736.2018.1528392

Microwave ablation of hyperplastic parathyroid glands is a treatment option for end-stage renal disease patients ineligible for surgical resection


Secondary Hyperparathyroidism
10.1001/jama.2019.14745

Chronic Kidney Disease Diagnosis and Management: A Review.


Secondary Hyperparathyroidism
10.1016/j.jocd.2019.06.005

Celiac Disease and Its Role in the Development of Metabolic Bone Disease.


Secondary Hyperparathyroidism
10.21037/ATM.2019.06.44

Cinacalcet attenuated bone loss via inhibiting parathyroid hormone-induced endothelial-to-adipocyte transition in chronic kidney disease rats.


Secondary Hyperparathyroidism
10.14341/osteo10190

Case report of Sagliker syndrome in a young patient with secondary hyperparathyroidism and chronic renal failure


Secondary Hyperparathyroidism
10.1007/s12020-019-01966-1

Long-term control of Paget’s disease of bone with low-dose, once-weekly, oral bisphosphonate preparations, in a “real world” setting


Secondary Hyperparathyroidism
10.1016/j.anorl.2018.09.003

Conservative three-quarter versus subtotal seven-eighths parathyroidectomy in secondary hyperparathyroidism.


Secondary Hyperparathyroidism
10.4103/err.err_57_18

Articular and skeletal affection in regularly dialyzed patients with end-stage renal disease


Secondary Hyperparathyroidism
10.1186/s41100-019-0213-z

Restoration of renal anemia following therapy with etelcalcetide for refractory secondary hyperparathyroidism: a case report with mini-review


Secondary Hyperparathyroidism
10.1016/j.ejphar.2018.10.021

Pharmacology of Parsabiv® (etelcalcetide, ONO‐5163/AMG 416), a novel allosteric modulator of the calcium‐sensing receptor, for secondary hyperparathyroidism in hemodialysis patients


Secondary Hyperparathyroidism
10.1080/0886022X.2019.1662439

Uncommon presentation of primary hyperaldosteronism with severe hypomagnesemia: a Gitelman syndrome mimic


Secondary Hyperparathyroidism
10.1186/s12882-019-1355-5

Predictors of cinacalcet discontinuation and reinitiation in hemodialysis patients: results from 7 European countries


Secondary Hyperparathyroidism
10.1210/JS.2019-SAT-509

SAT-509 Denosumab Use in Tertiary Hiperparathyroidism with Fracture


Secondary Hyperparathyroidism
10.1308/rcsann.2019.0105

Parathyromatosis: a very rare cause of recurrent primary hyperparathyroidism - case report and review of the literature.


Secondary Hyperparathyroidism
10.33594/000000148

A Multi-Compartment Model Capturing the Pharmacokinetics of the Calcimimetic Cinacalcet.


Secondary Hyperparathyroidism
10.1080/07435800.2018.1509868

Endocrine complications of celiac disease: a case report and review of the literature


Secondary Hyperparathyroidism
10.1016/J.AMJOTO.2019.05.009

Efficacy analysis of medical and surgical treatments in chronic kidney disease patients with secondary hyperparathyroidism.


Secondary Hyperparathyroidism
10.1111/1744-9987.12760

Comparison of Paricalcitol and Calcitriol in Dialysis Patients With Secondary Hyperparathyroidism: A Meta‐Analysis of Randomized Controlled Studies


Secondary Hyperparathyroidism
10.3760/CMA.J.ISSN.1001-7097.2019.06.006

Parathyroid hormone induces endothelial-to-adipocyte transition in endothelial cells by Wnt/β-catenin pathway


Secondary Hyperparathyroidism
10.1177/0300060518794840

A practical self-made device in parathyroid autotransplantation for patients with secondary hyperparathyroidism


Secondary Hyperparathyroidism
10.1016/j.ekir.2019.04.010

Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients


Secondary Hyperparathyroidism
10.13201/j.issn.1001-1781.2019.07.020

[Surgical treatment of uremic secondary hyperparathyroidism complicated with thyroid nodules].


Secondary Hyperparathyroidism
10.1007/s11695-019-03797-5

Bone Metabolism in Adolescents and Adults Undergoing Roux-En-Y Gastric Bypass: a Comparative Study


Secondary Hyperparathyroidism
10.1007/978-3-319-99817-6_50

Hyperparathyroidism and Hypoparathyroidism


Secondary Hyperparathyroidism
10.1186/s12893-019-0603-8

Effects of parathyroidectomy on tumoral calcinosis in uremic patients with secondary hyperparathyroidism


Secondary Hyperparathyroidism
10.1007/s11255-019-02271-6

Cinacalcet plus vitamin D versus vitamin D alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: a meta-analysis of randomized controlled trials


Secondary Hyperparathyroidism
10.3877/CMA.J.ISSN.2095-3216.2019.04.006

Therapeutic evaluation of total parathyroidectomy with autotransplantation in the treatment of secondary hyperparathyroidism


Secondary Hyperparathyroidism
10.1007/s40618-019-01075-w

Parathyroid hormone reference ranges in healthy individuals classified by vitamin D status


Secondary Hyperparathyroidism
10.1111/1744-9987.13434

Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism


Secondary Hyperparathyroidism
10.1080/02656736.2019.1627429

Efficacy and safety of microwave ablation for ectopic secondary hyperparathyroidism: a feasibility study


Secondary Hyperparathyroidism
10.1016/J.DSX.2019.06.022

Challenges in management of diabetic ketoacidosis in hemodialysis patients, case presentation and review of literature.


Secondary Hyperparathyroidism
10.1159/000504139

Cinacalcet Treatment Significantly Improves All-Cause and Cardiovascular Survival in Dialysis Patients: Results from a Meta-Analysis


Secondary Hyperparathyroidism
10.3760/CMA.J.ISSN.2095-428X.2019.17.004

Mineral and bone disorder in children with chronic kidney disease


Secondary Hyperparathyroidism
10.1007/s11695-019-04121-x

Letter to the Editor Concerning: Fractures in Adults After Weight Loss from Bariatric Surgery and Weight Management Programs for Obesity: Systematic Review and Meta-analysis


Secondary Hyperparathyroidism
10.1007/s13304-019-00652-1

Intraoperative verification of parathyroid glands in primary and secondary hyperparathyroidism using near-infrared autofluorescence (IOPA)


Secondary Hyperparathyroidism
10.1016/j.xkme.2019.05.005

Dialysate Calcium: A Lot More Than ‘Set It and Forget It’


Secondary Hyperparathyroidism
10.1177/1071100719864325

Vitamin D Deficiency in Patients With Idiopathic and Traumatic Osteochondritis Dissecans of the Talus


Secondary Hyperparathyroidism
10.1007/s00467-019-04423-3

Proptosis in a child with chronic kidney disease: Answers


Secondary Hyperparathyroidism
10.1002/jcla.22696

Parathyroidectomy decreases serum intact parathyroid hormone and calcium levels and prolongs overall survival in elderly hemodialysis patients with severe secondary hyperparathyroidism


Secondary Hyperparathyroidism
10.1007/s11695-019-04138-2

Letter to the Editor Concerning “The Impact of Roux-en-Y Gastric Bypass on Bone Remodeling Expressed by the P1NP/βCTX Ratio: a Single-Center Prospective Cohort Study”


Secondary Hyperparathyroidism
10.1016/j.ebiom.2019.07.014

Paricalcitol accelerates BACE1 lysosomal degradation and inhibits calpain-1 dependent neuronal loss in APP/PS1 transgenic mice


Secondary Hyperparathyroidism
10.1016/j.bone.2019.06.025

Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients.


Secondary Hyperparathyroidism
10.1007/S11695-018-03624-3

Secondary Hyperparathyroidism in Patients with Biliopancreatic Diversion After 10 Years of Follow-up, and Relationship with Vitamin D and Serum Calcium.


Secondary Hyperparathyroidism
10.1159/000496808

Effects of Long-Term Cinacalcet Administration on Parathyroid Gland in Hemodialysis Patients with Secondary Hyperparathyroidism


Secondary Hyperparathyroidism
10.1177/0194599818825467

Relationship of Vitamin D Deficiency and Intraoperative Parathyroid Hormone Elevation in Completion and Total Thyroidectomy


Secondary Hyperparathyroidism
10.4103/AJIR.AJIR_37_18

Effectiveness of percutaneous ethanol injection therapy compared to parathyroidectomy in the management of secondary and tertiary hyperparathyroidism


Secondary Hyperparathyroidism
10.1016/j.amsu.2019.07.016

Unique classification of parathyroid dysfunction in patients with transfusion dependent thalassemia major using Nomogram-A cross sectional study


Highly Related Keywords of Secondary Hyperparathyroidism